3.3 Independent Pharmacist Furnishing Scope

Pharmacist Independent Furnishing Authority

Under Business and Professions Code (B&P) § 4052, California pharmacists have been granted extensive independent furnishing authority to improve public health access. "Furnishing" means supplying a prescription drug to a patient without a direct prescription from a physician, acting instead under a statewide protocol or statutory authority. This represents a major shift toward pharmacists acting as independent healthcare providers in specific clinical areas.

1. Self-Administered Hormonal Contraception (16 CCR § 1746.1)

Pharmacists are authorized to furnish self-administered hormonal contraceptives, which include oral contraceptive pills, transdermal patches, vaginal rings, and depot medroxyprogesterone acetate (DMPA) injections. The protocol requires the pharmacist to follow a specific step-by-step procedure:

1. Patient Screening: The pharmacist must have the patient complete a self-screening tool (often the US MEC-based questionnaire) to identify any contraindications, such as a history of deep vein thrombosis, breast cancer, or uncontrolled hypertension.
2. Blood Pressure Check: If the requested contraceptive contains estrogen, the pharmacist must measure and record the patient's seated blood pressure.
3. Counseling: The pharmacist must provide counseling on the proper use of the contraceptive, potential side effects, the importance of STI protection (as contraceptives do not protect against STIs), and what to do if doses are missed.
4. Fact Sheet: The pharmacist must provide a birth control guide or fact sheet, such as the CDC or FDA-approved information.
5. Record Keeping and Notification: The pharmacist must document the encounter, maintain records for at least three years, and notify the patient's primary care provider (if the patient has one and consents to notification).

2. Naloxone for Opioid Overdose (16 CCR § 1746.3)

To combat the opioid epidemic, pharmacists can furnish naloxone hydrochloride to individuals at risk of an opioid-related overdose or to family members, friends, or other persons in a position to assist an at-risk individual.

1. Screening: The pharmacist screens the individual to determine if they understand the signs of an overdose.
2. Training and Counseling: The pharmacist must provide counseling on overdose prevention, recognition, and response (including calling 911), and demonstrate how to administer the naloxone (intranasal, intramuscular, or auto-injector).
3. Fact Sheet: The pharmacist provides the recipient with a fact sheet approved by the Board.
4. Record Keeping: The pharmacy must keep records of the furnishing for at least three years. Interestingly, the recipient's identity is strictly confidential, and if they are acquiring it for someone else, the pharmacist does not need to identify the ultimate user.

3. Nicotine Replacement Therapy (16 CCR § 1746.2)

Pharmacists can furnish prescription Nicotine Replacement Therapy (NRT), such as nicotine inhalers and nicotine nasal sprays, as well as over-the-counter NRTs.

1. Training Requirement: The pharmacist must complete an approved training program in smoking cessation.
2. Screening: The pharmacist screens the patient for pregnancy (if pregnant, refer to a provider), recent heart attacks, irregular heartbeats, or severe angina. If these high-risk conditions are present, furnishing must be coordinated with the patient's primary care provider.
3. Counseling: The pharmacist counsels on behavioral modification strategies and the proper use of the NRT.
4. Notification: The patient's primary care provider must be notified.

4. HIV Pre-Exposure (PrEP) and Post-Exposure (PEP) Prophylaxis (16 CCR § 1747)

Pharmacists play a critical role in HIV prevention by furnishing PrEP and PEP.

• PrEP (Pre-Exposure Prophylaxis): Pharmacists can furnish up to a 60-day supply of PrEP (e.g., tenofovir disoproxil fumarate/emtricitabine). The pharmacist must ensure the patient has a negative HIV test result within the last 7 days. If the patient does not have a test result, the pharmacist can order an HIV test. The pharmacist provides counseling on adherence and safe sex practices. Pharmacists cannot furnish more than a 60-day supply to a single patient more frequently than once every two years without a prescription.
• PEP (Post-Exposure Prophylaxis): Pharmacists can furnish a complete 28-day course of PEP for individuals who may have been exposed to HIV within the last 72 hours. The pharmacist must screen the patient for exposure risk, offer HIV testing (though furnishing PEP is not strictly contingent on an immediate test result if it delays care), and provide extensive counseling on the 28-day regimen.

For both PrEP and PEP, the pharmacist must notify the patient's primary care provider (with consent) and keep detailed records. Pharmacists must undergo specialized training approved by the Board before furnishing PrEP/PEP.

Summary Table of Furnishing Requirements